Epigenetics of Sleep Disorders

A special issue of Neurology International (ISSN 2035-8377).

Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 3978

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, University of Missouri, Columbia, MO 65211, USA
Interests: epigenomics; sleep disorders; multiomics; obstructive sleep apnea; developmental origin of diseases; circulating DNA; liquid biopsies; cognitive disorders; cardiometabolic disorders; cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Sleep disorders are common conditions disturbing sleep patterns in adults and children. They represent a wide spectrum including sleep disruption, insomnia, restless leg syndrome, hypersomnia (e.g., narcolepsy), circadian rhythm disorders, parasomnias, and sleep disordered breathing (e.g., sleep apnea). Sleep disorders entail problems with the quality, timing, and amount of sleep, which result in daytime distress and impairment in functioning. Furthermore, numerous and serious morbidities are associated with sleep disorders, virtually affecting every organ and system. Sleep disorders have been associated with the occurrence of metabolic, cardiovascular, and cognitive disorders, as well as tumor aggressiveness and poor prognosis in cancer.

Epigenetics refers to the study of heritable changes in genome function that occur without a change in DNA sequence. Assessment and evaluation of epigenomic profiles have currently a fundamental role in understanding, diagnosing, and treating complex pathologies. Changes in epigenetic profiles are among the most common molecular alterations in virtually all complex diseases including cancer, diabetes, metabolic syndrome, atherosclerosis, inflammatory bowel disease, autoimmune diseases, and psychiatric and neurodegenerative disorders. The role of epigenetic regulation in sleep disorders is starting to be recognized. New diagnostic opportunities may arise from the identification of epigenetic alterations that may provide high sensitivity and specificity for detecting, monitoring, and predicting the outcome of sleep disorders.

This Special Issue is dedicated to reviewing and presenting new data from current research on the role of epigenetics in the pathophysiology of sleep disorders and the application of epigenetic markers for the diagnosis of sleep disorders and their comorbidities.

You may choose our Joint Special Issue in Diagnostics.

Dr. Rene Cortese
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • DNA methylation
  • Histone modifications
  • Non-coding RNA
  • Epigenetics
  • Sleep disorders
  • Molecular diagnostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

7 pages, 1893 KiB  
Case Report
SARS-CoV-2 Infection Causes Relapse of Kleine-Levin Syndrome: Case Report and Review of Literature
by Marino Marčić, Ljiljana Marčić and Barbara Marčić
Neurol. Int. 2021, 13(3), 328-334; https://doi.org/10.3390/neurolint13030033 - 20 Jul 2021
Cited by 13 | Viewed by 3310
Abstract
Recurrent episodes of hypersomnia, hypersexuality, compulsive eating, behavioral and cognitive disturbances, are the basic clinical features of Kleine-Levin syndrome (KLS). Our case report describes a patient who was diagnosed with KLS at the age of 20. With appropriate therapy, the disease had a [...] Read more.
Recurrent episodes of hypersomnia, hypersexuality, compulsive eating, behavioral and cognitive disturbances, are the basic clinical features of Kleine-Levin syndrome (KLS). Our case report describes a patient who was diagnosed with KLS at the age of 20. With appropriate therapy, the disease had a satisfactory course until patient had a moderate form of SARS-CoV-2 infection, which led to a significant exacerbation of all symptoms. SARS-CoV-2 virus can cause almost any neurological disease, and relapse of KLS is another evidence of neurotropicity of the virus. Full article
(This article belongs to the Special Issue Epigenetics of Sleep Disorders)
Show Figures

Figure 1

Back to TopTop